Intermediates to 1,9-dihydroxyoctahydrophenanthrenes

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26032633, 42424852, 42424855, 424250, 424267, 424274, 424350, 424311, 544130, 544131, 544155, 544360, 544380, 546188, 546189, 546190, 546194, 546204, 546208, 546281, 546285, 560134, 560139, A61K 3144, A61K 31445, C07D21350, C07D21355

Patent

active

043105297

ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, benzyl, benzoyl, alkanoyl of 1 to 5 carbon atoms or --CO--(CH.sub.2).sub.p --NR'R" wherein p is 0 or an integer from 1 to 4; each of R' and R" when taken individually is hydrogen or alkyl of 1 to 4 carbon atoms; R' and R" when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrrolo, pyrrolidino, morpholino and N-alkylpiperazino having from 1 to 4 carbon atoms in the alkyl group;

REFERENCES:
patent: 2750382 (1956-06-01), Bible et al.
patent: 2764616 (1956-09-01), Hoehn et al.
Chemical Abstracts, 50:11356e, (1956), [Kalvoda, J., et al., Helv. Chim. Acta., 38, 1847-56, (1955)].

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Intermediates to 1,9-dihydroxyoctahydrophenanthrenes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermediates to 1,9-dihydroxyoctahydrophenanthrenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates to 1,9-dihydroxyoctahydrophenanthrenes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1541126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.